MRS. CATHERINE ANNE FINNEGAN, MS,CRNP
Nursing at Eastern Ave, Baltimore, MD
License number
Maryland R080300
Category
Nursing
Type
Neonatal
Address
Address
4940 Eastern Ave, Baltimore, MD 21224
Phone
(410) 550-0395
(410) 550-0439 (Fax)
(410) 335-8148
(410) 550-0439 (Fax)
(410) 335-8148
Personal information
See more information about CATHERINE ANNE FINNEGAN at radaris.comName
Address
Phone
614 Waterside Ct, Middle River, MD 21220
116 Mountain Rd UNIT 1C, Glen Burnie, MD 21060
2117 Gough St, Baltimore, MD 21231
614 Waterside Ct, Middle River, MD 21220
3715 Double Rock Ln, Parkville, MD 21234
Professional information
See more information about CATHERINE ANNE FINNEGAN at trustoria.com
Computer Software Consultant And Contractor
Computer Software Consultant And Contractor
Location:
Baltimore, Maryland Area
Industry:
Computer Software
Education:
University of Kentucky
Master's degree, Microbiology and Immunology
Master's degree, Microbiology and Immunology
Catherine A Finnegan, Baltimore MD - MS (Mitral stenosis; also Master of Science or Medical scientist)
Catherine A Finnegan, Baltimore MD - MS (Mitral stenosis; also Master of Science or Medical scientist)
Specialties:
Nursing (Nurse Practitioner), Neonatal Nursing (Nurse Practitioner)
Address:
4940 Eastern Ave, Baltimore 21224
(410) 550-0395 (Phone), (410) 550-0439 (Fax)
(410) 550-0395 (Phone), (410) 550-0439 (Fax)
Languages:
English
Hospitals:
4940 Eastern Ave, Baltimore 21224
Johns Hopkins Bayview Medical Center
4940 Eastern Ave, Baltimore 21224
Johns Hopkins Bayview Medical Center
4940 Eastern Ave, Baltimore 21224
Catherine Anne Finnegan, Baltimore MD
Catherine Anne Finnegan, Baltimore MD
Specialties:
Nurse Practitioner
Address:
4940 Eastern Ave, Baltimore, MD 21224
Alpha-Substituted Arylmethyl Piperazine Pyrazolo [1,5-Alpha]Pyrimidine Amide Derivatives
Alpha-Substituted Arylmethyl Piperazine Pyrazolo [1,5-Alpha]Pyrimidine Amide Derivatives
US Patent:
2009021, Aug 27, 2009
Filed:
Apr 28, 2008
Appl. No.:
12/149178
Inventors:
Theodore J. Nitz - Boyds MD, US
Karl Salzwedel - Olney MD, US
Catherine Finnegan - Baltimore MD, US
Shirley Brunton - Windsor, GB
Stuart Flanagan - Wallingford, GB
Christian Montalbetti - Wallingford, GB
Thomas Stephen Coulter - Oxfordshire Wantage, GB
Karl Salzwedel - Olney MD, US
Catherine Finnegan - Baltimore MD, US
Shirley Brunton - Windsor, GB
Stuart Flanagan - Wallingford, GB
Christian Montalbetti - Wallingford, GB
Thomas Stephen Coulter - Oxfordshire Wantage, GB
Assignee:
Panacos Pharmaceuticals, Inc. - Gaithersburg MD
International Classification:
C07D 487/04, A61K 31/496, A61K 31/519, A61K 31/5377, A61P 31/18
US Classification:
5142358, 544281, 51425216, 51425211, 544121
Abstract:
Derivatives of pyrazolopyrimidine compounds represented by Formula I are disclosed:These pyrazolopyrimidine derivatives and pharmaceutical compositions comprising these derivatives are useful in the treatment of HIV mediated diseases and conditions.
Methods For Inhibiting Hiv And Other Viral Infections By Modulating Ceramide Metabolism
Methods For Inhibiting Hiv And Other Viral Infections By Modulating Ceramide Metabolism
US Patent:
2007025, Nov 8, 2007
Filed:
Dec 9, 2004
Appl. No.:
10/582411
Inventors:
Robert Blumenthal - Bethesda MD, US
Catherine Finnegan - Baltimore MD, US
Catherine Finnegan - Baltimore MD, US
International Classification:
A61K 31/165, A61K 31/07, A61K 31/20, A61K 31/203, A61K 38/46, A61P 31/18, C12Q 1/00
US Classification:
424094600, 435004000, 514559000, 514622000, 514725000
Abstract:
The present invention provides methods of preventing infection by retroviruses and methods of treatment of patients suffering from or susceptible to a viral infection. More particularly, the present invention provides methods of preventing viral infection and methods of treating retroviral infections which comprise the administration of at least one compound comprising N-4-(hydroxyphenyl)retinamide. Preferred methods of the invention are suitable for use in the treatment of patients who are HIV positive or are suffering from or are susceptible to AIDS.